首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   31785篇
  免费   2123篇
  国内免费   31篇
耳鼻咽喉   515篇
儿科学   1341篇
妇产科学   1086篇
基础医学   4443篇
口腔科学   1765篇
临床医学   3031篇
内科学   5500篇
皮肤病学   429篇
神经病学   2975篇
特种医学   1080篇
外科学   4452篇
综合类   154篇
一般理论   2篇
预防医学   2499篇
眼科学   536篇
药学   2201篇
中国医学   36篇
肿瘤学   1894篇
  2021年   278篇
  2020年   366篇
  2019年   479篇
  2018年   631篇
  2017年   540篇
  2016年   559篇
  2015年   591篇
  2014年   690篇
  2013年   1200篇
  2012年   1382篇
  2011年   1396篇
  2010年   859篇
  2009年   893篇
  2008年   1209篇
  2007年   1361篇
  2006年   1357篇
  2005年   1383篇
  2004年   1190篇
  2003年   1159篇
  2002年   1088篇
  2001年   1059篇
  2000年   1019篇
  1999年   953篇
  1998年   345篇
  1997年   294篇
  1996年   273篇
  1995年   303篇
  1994年   282篇
  1993年   226篇
  1992年   762篇
  1991年   713篇
  1990年   756篇
  1989年   736篇
  1988年   692篇
  1987年   674篇
  1986年   604篇
  1985年   557篇
  1984年   503篇
  1983年   389篇
  1982年   242篇
  1981年   213篇
  1979年   362篇
  1978年   263篇
  1977年   214篇
  1976年   205篇
  1975年   237篇
  1974年   257篇
  1973年   223篇
  1972年   210篇
  1971年   204篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Clinical Oral Investigations - Mechanisms of wound healing are often impaired in patients with osteonecrosis of the jaw (ONJ). According to the guidelines for the treatment of this disease, early...  相似文献   
3.
4.
Journal of Clinical Immunology - Coronavirus disease 2019 (COVID-19) exhibits a wide spectrum of clinical manifestations, ranging from asymptomatic to critical conditions. Understanding the...  相似文献   
5.
6.
The aim of this safety study in mice was to determine m>in vivom> toxicity and biodistribution potential of a single and multiple doses of L-glutamic acid-g-p(HEMA) polymeric nanoparticles as a drug delivery system. The single dose did not cause any lethal effect, and its acute oral LD50 was >2.000 mg/kg body weight (bw). Multiple doses (25, 50, or 100 mg/kg bw) given over 28 days resulted in no significant differences in body and relative organ weights compared to control. These results are supported by biochemical and histological findings. Moreover, nanoparticle exposure did not result in statistically significant differences in micronucleus counts in bone marrow cells compared to control. Nanoparticle distribution was time-dependent, and they reached the organs and even bone marrow by hour 6, as established by m>ex vivom> imaging with the IVIS® spectrum imaging system. In conclusion, L-glutamic acid-g-p(HEMA) polymeric nanoparticles appear biocompatible and have a potential use as a drug delivery system.KEY WORDS: biocompatibility, blood biochemistry, genotoxicity, histology, m>in vivom> toxicity, micronucleus test, polymers  相似文献   
7.
Journal of Clinical Immunology - Inborn errors of immunity (IEI) and autoantibodies to type I interferons (IFNs) underlie critical COVID-19 pneumonia in at least 15% of the patients, while the...  相似文献   
8.
9.

Background

Weaning from mechanical ventilation and tracheostomy after prolonged intensive care consume enormous resources with optimal management not currently well described. Restoration of respiratory flow via the upper airway is essential and early cuff-deflation using a one-way valve (OWV) is recommended. However, extended OWV use may cause dry airways and thickened secretions which challenge the weaning process. High-flow therapy via the tracheostomy tube (HFT-T) humidifies inspired air and may be connected via an in-line OWV (HFT-T-OWV) alleviating these problems. We aim to provide clinical and experimental data on the safety of HFT-T-OWV along with a practical guide to facilitate clinical use during weaning from mechanical ventilation and tracheostomy.

Methods

Data on adverse events of HFT-T-OWV were retrieved from a quality register for patients treated at an intensive care rehabilitation center between 2019 and 2022. Benchtop experiments were performed to measure maximum pressures and pressure support generated by HFT-T-OWV at 25–60 L/min flow using two different HFT-T adapters (interfaces). In simulated airway obstruction using a standard OWV (not in-line) maximum pressures were measured with oxygen delivered via the side port at 1–3 L/min.

Results

Of 128 tracheostomized patients who underwent weaning attempts, 124 were treated with HFT-T-OWV. The therapy was well tolerated, and no adverse events related to the practice were detected. The main reason for not using HFT-T-OWV was partial upper airway obstruction using a OWV. Benchtop experiments demonstrated HFT-T-OWV maximum pressures <4 cmH2O and pressure support 0–0.6 cmH2O. In contrast, 1–3 L/min supplemental oxygen via a standard OWV caused pressures between 84 and 148 cmH2O during simulated airway obstruction.

Conclusions

Current study clinical data and benchtop experiments indicate that HFT-T-OWV was well tolerated and appeared safe. Pressure support was low, but humidification may enable extended use of a OWV without dry airway mucosa and thickened secretions. Results suggest the treatment could offer advantages to standard OWV use, with or without supplementary oxygen, as well as to HFT-T without a OWV, for weaning from mechanical ventilation and tracheostomy. However, for definitive treatment recommendations, randomized clinical trials are needed.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号